Syquant Capital Sas Genfit S.A. Put Options Transaction History
Syquant Capital Sas
- $141 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GNFT
# of Institutions
9Shares Held
209KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny131KShares$553,5430.0% of portfolio
-
Morgan Stanley New York, NY25.5KShares$107,4390.0% of portfolio
-
Old Mission Capital LLC22.2KShares$93,6210.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P713.2KShares$55,3820.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.3KShares$51,9130.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $210M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...